Fluconazole Exposure in Plasma and Bile During Continuous Veno-venous Hemodialysis

摘要

We would like to report the fluconazole pharmacokinetic (PK) profile of a 17-year-old patient treated for biliary and peritoneal candidiasis during continuous venovenous hemodialysis (CVVHD). The patient suffered from B-cell lymphoma and responded well to the treatment but presented with anuric renal failure at day 6, requiring CVVHD (Baxter).